1. Home
  2. IPSC vs BFIN Comparison

IPSC vs BFIN Comparison

Compare IPSC & BFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • BFIN
  • Stock Information
  • Founded
  • IPSC 2019
  • BFIN 1924
  • Country
  • IPSC United States
  • BFIN United States
  • Employees
  • IPSC N/A
  • BFIN N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • BFIN Savings Institutions
  • Sector
  • IPSC Health Care
  • BFIN Finance
  • Exchange
  • IPSC Nasdaq
  • BFIN Nasdaq
  • Market Cap
  • IPSC 43.6M
  • BFIN 145.5M
  • IPO Year
  • IPSC 2021
  • BFIN N/A
  • Fundamental
  • Price
  • IPSC $0.50
  • BFIN $12.12
  • Analyst Decision
  • IPSC Strong Buy
  • BFIN Hold
  • Analyst Count
  • IPSC 5
  • BFIN 1
  • Target Price
  • IPSC $3.33
  • BFIN $11.50
  • AVG Volume (30 Days)
  • IPSC 603.4K
  • BFIN 102.7K
  • Earning Date
  • IPSC 11-04-2025
  • BFIN 11-04-2025
  • Dividend Yield
  • IPSC N/A
  • BFIN 3.26%
  • EPS Growth
  • IPSC N/A
  • BFIN N/A
  • EPS
  • IPSC N/A
  • BFIN 0.16
  • Revenue
  • IPSC $114,128,000.00
  • BFIN $45,545,000.00
  • Revenue This Year
  • IPSC $1,589.94
  • BFIN N/A
  • Revenue Next Year
  • IPSC N/A
  • BFIN $6.40
  • P/E Ratio
  • IPSC N/A
  • BFIN $78.37
  • Revenue Growth
  • IPSC 5491.77
  • BFIN N/A
  • 52 Week Low
  • IPSC $0.34
  • BFIN $10.69
  • 52 Week High
  • IPSC $1.86
  • BFIN $13.97
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 43.47
  • BFIN 51.00
  • Support Level
  • IPSC $0.46
  • BFIN $12.17
  • Resistance Level
  • IPSC $0.52
  • BFIN $12.45
  • Average True Range (ATR)
  • IPSC 0.03
  • BFIN 0.23
  • MACD
  • IPSC 0.00
  • BFIN -0.04
  • Stochastic Oscillator
  • IPSC 41.33
  • BFIN 6.72

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About BFIN BankFinancial Corporation

BankFinancial Corp is a full-service, national bank providing banking, financial planning and fiduciary services to individuals, families and businesses in the Chicago metropolitan area and on a regional or national basis for commercial finance, healthcare finance, equipment finance, commercial real estate finance and treasury management business customers. The Bank offers its customers a broad range of loan, deposit, trust and other financial products and services through approximately 18 full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through its Internet Branch.

Share on Social Networks: